All Approved Drugs Similarly Prevent Migraines

Review: All Approved Drugs Similarly Prevent Migraines

(HealthDay News) – There is no significant difference in effectiveness in approved drugs for preventing episodic migraine frequency by ≥50%, according to a review published in the April issue of the Journal of General Internal Medicine.

Tatyana A. Shamliyan, MD, from the University of Minnesota in Minneapolis, and colleagues conducted a literature review to identify randomized controlled trials (RCTs) of preventive drugs vs. placebo or active treatments examining rates of ≥50% reduction in monthly migraine frequency or improvement in quality of life.